RxDoctor Payments Data

Abbigale Carmichael, PA

Physician Assistant · Great Falls, MTNPI 1699498469

Payments from drug & device makers

$829in general payments, 2019–2025

Across 25 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$249
  • Lilly USA, LLC$145
  • Amgen$104
  • Daiichi Sankyo Inc.$57
  • AbbVie$51
  • Exact Sciences$43
  • plus $180 from 8 others

What the payments were for

  • Food & beverage$829100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$829 in reported general payments places this provider in the 85th percentile of 626 physician assistant providers in Montana.

See all physician assistant providers in Montana

Medicare billing

Part B allowed, 2024
$323
Medicare patients
14
Services billed
27

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide14$12,978
TrulicityDulaglutide13$12,187
JardianceEmpagliflozin19$11,627
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,484
EliquisApixaban52$8,121
Varenicline Tartrate16$1,538
Metoprolol Succinate104$1,429
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,208
Albuterol Sulfate HfaAlbuterol Sulfate42$1,121
Olanzapine71$1,039
Ventolin HfaAlbuterol Sulfate15$835
Amlodipine Besylate87$783
Buspirone Hcl58$731
Metformin Hcl ErMetformin Hcl77$685
Rosuvastatin Calcium66$669

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Olanzapine$145$13,22684 claims
Novo NordiskOzempic$17$12,97814 claims
GSKTrelegy Ellipta$33$9,48415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 626 physician assistant providers in Montana.

Other physician assistant in Great Falls

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →